Skip to main content
. 2014 Apr 15;7(4):1064–1070.

Table 1.

Clinical features for the groups

Group-1 Group-2 p

n=104 n=36
Age (years) 59.8±10.7 60.8±12.4 0.66
Men, n (%) 91 (87.5) 32 (88.9) 1.0
Diabetes mellitus, n (%) 16 (15.4) 2 (5.6) 0.15
Hypertension, n (%) 54 (51.9) 16 (44.4) 0.56
Hypercholesterolemia, n (%) 38 (36.5) 7 (19.4) 0.09
Family history of CAD, n (%) 42 (40.4) 9 (25.0) 0.14
Current smoker, n (%) 63 (60.6) 18 (50.0) 0.36
Previous MI, n (%) 7 (6.7) 0 (0.0) 0.19
Previous PCI, n (%) 8 (7.7) 1 (2.8) 0.44
Periferic vascular disease, n (%) 0 (0.0) 2 (5.6) 0.06
Initial Killip class ≥II, n (%) 6 (5.8) 0 (0.0) 0.33
Multivessel disease, n (%) 63 (60.6) 22 (61.1) 1.0
Baseline hemoglobin (g/dl) 14.3±1.7 14.0±1.5 0.49
Baseline hematocrit (%) 41.5±5.3 41.0±4.7 0.65
Baseline WBC count (x109/L) 10962.7±3166.2 10141.6±3633.6 0.19
Baseline platelet count (x109/L) 287.2±62.4 239.3±53.1 <0.0001
Baseline serum creatinine (mg/dl) 0.8±0.5 0.7±0.4 0.09
Symptom onset to ballon inflation (h) 4.4±2.4 4.9±2.7 0.2
No. Of coronary arteries narrowed
    1 vessel 41 (39.4) 14 (38.9) 1.0
    2 vessel 37 (35.6) 9 (25.0) 0.33
    3 vessel 26 (25.0) 13 (36.1) 0.28
Left ventricular ejection fraction (%) 38.6±6.5 44.1±6.1 <0.0001

MI: Myocard Infarction; PCI: Percutaneous Coronary Intervention; WBC: White Blood Cell.